Jonathan Yong
Stock Analyst at UBS
(3.18)
# 1,139
Out of 4,734 analysts
110
Total ratings
57.89%
Success rate
9.54%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Initiates: Neutral | $5.5 | $9.99 | -44.94% | 4 | Dec 4, 2024 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $4.24 | -5.66% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $15.65 | +46.96% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $22.09 | +13.17% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.37 | +163.85% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.99 | +50.19% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.71 | +69.85% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $18.21 | +42.78% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $29.81 | -53.04% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $74.19 | +29.40% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $19.33 | +65.55% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $27.10 | +287.45% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $95.79 | -16.48% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $243.99 | -5.32% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $92.18 | +9.57% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $9.50 | +184.21% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $6.88 | +118.02% | 5 | Jun 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $38 | $30.95 | +22.78% | 2 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $127.83 | -21.77% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $586.08 | -23.22% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.41 | +172.11% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $10.98 | +537.52% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $11.82 | +43.82% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $297.44 | +17.67% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $44.37 | +114.11% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $15.06 | -43.56% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.73 | +80.38% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $14.92 | +13.94% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.30 | +157.58% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $77.78 | +9.28% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $152.65 | -4.36% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $63.66 | +66.51% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $188.78 | -16.83% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $288.59 | +27.52% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $284.67 | +123.07% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $53.15 | +120.13% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $14.00 | +114.29% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $318.47 | -6.43% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $134.43 | -29.33% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $524.99 | -5.71% | 1 | Oct 15, 2021 |
eHealth
Dec 4, 2024
Initiates: Neutral
Price Target: $5.5
Current: $9.99
Upside: -44.94%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $4.24
Upside: -5.66%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $15.65
Upside: +46.96%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $22.09
Upside: +13.17%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.37
Upside: +163.85%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.99
Upside: +50.19%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.71
Upside: +69.85%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $18.21
Upside: +42.78%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $29.81
Upside: -53.04%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $74.19
Upside: +29.40%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $19.33
Upside: +65.55%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $27.10
Upside: +287.45%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $95.79
Upside: -16.48%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $243.99
Upside: -5.32%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $92.18
Upside: +9.57%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $9.50
Upside: +184.21%
Jun 30, 2023
Maintains: Neutral
Price Target: $13 → $15
Current: $6.88
Upside: +118.02%
Jun 22, 2023
Maintains: Outperform
Price Target: $35 → $38
Current: $30.95
Upside: +22.78%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $127.83
Upside: -21.77%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $586.08
Upside: -23.22%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.41
Upside: +172.11%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $10.98
Upside: +537.52%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $11.82
Upside: +43.82%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $297.44
Upside: +17.67%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $44.37
Upside: +114.11%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $15.06
Upside: -43.56%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.73
Upside: +80.38%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $14.92
Upside: +13.94%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.30
Upside: +157.58%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $77.78
Upside: +9.28%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $152.65
Upside: -4.36%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $63.66
Upside: +66.51%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $188.78
Upside: -16.83%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $288.59
Upside: +27.52%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $284.67
Upside: +123.07%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $53.15
Upside: +120.13%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $14.00
Upside: +114.29%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $318.47
Upside: -6.43%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $134.43
Upside: -29.33%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $524.99
Upside: -5.71%